TD Synnex Corp Reports Strong Q4 Revenue, Stock Hits 20-Day Low
TD Synnex Corp's stock fell by 3.07% today, hitting a 20-day low, amid a broader market decline with the Nasdaq-100 down 0.72% and the S&P 500 down 0.05%.
This decline occurs despite the company reporting fourth-quarter revenue of $17.4 billion, exceeding analyst expectations and marking a 9.7% year-over-year increase. The positive earnings report reflects strong performance in the IT services sector, yet the stock's movement suggests sector rotation as investors react to broader market conditions.
The implications of this price movement indicate that while TD Synnex's fundamentals remain strong, investor sentiment may be shifting due to external market pressures, highlighting the volatility in the current economic environment.
Trade with 70% Backtested Accuracy
Analyst Views on SNX
About SNX
About the author

- Healthcare Revenue Recovery: Iterate.ai, in collaboration with TD SYNNEX and HPE, has launched Generate for Healthcare, a solution designed to help hospital systems identify and recover millions in unpaid and underpaid insurance claims, addressing a critical financial challenge in the healthcare sector.
- Technological Advantage: The solution operates on HPE Private Cloud AI and NVIDIA technology, enabling seamless integration across multiple EMR systems to identify payment gaps and coding errors in real-time, thereby enhancing financial transparency and operational efficiency for hospitals.
- Market Opportunity: The implementation of Generate for Healthcare is expected to deliver significant financial returns for hospitals, with software costs representing only 0.1% of net patient revenue, while optimizing operations and accelerating revenue inflow to help hospitals navigate increasingly complex financial environments.
- Strategic Partnerships: By partnering with HPE and TD SYNNEX, Iterate.ai not only strengthens its market competitiveness but also provides partners with innovative solutions that address payment erosion in healthcare, driving business growth and differentiation.
- Revenue Recovery Solution: Iterate.ai's Generate for Healthcare, launched in partnership with TD SYNNEX and HPE, aims to help hospital systems identify and recover millions in unpaid and underpaid insurance claims, addressing a critical financial challenge in the healthcare sector.
- Technological Architecture Advantage: The solution, built on HPE Private Cloud AI and NVIDIA technology, seamlessly integrates with multiple EMR systems to identify payment gaps and coding errors in real-time, significantly enhancing financial transparency and operational efficiency for hospitals.
- Market Opportunity: The implementation cost of Generate for Healthcare represents only 0.1% of net patient revenue, providing healthcare organizations with a substantial revenue opportunity while helping partners stand out in a competitive market.
- Strategic Collaboration: By partnering with HPE and TD SYNNEX, Iterate.ai can rapidly bring this solution to market, ensuring hospitals can quickly deploy it and realize financial benefits, further solidifying its leadership position in the healthcare AI space.
Rising Dividends: Several stocks, particularly in the data center sector, have significantly increased their dividends, with some raising payouts by as much as 60%, indicating strong earnings stability and potential for income investors.
CenterPoint Energy Performance: CenterPoint Energy is projected to deliver a total return of approximately 24% in 2025, supported by data center expansion and a forecasted increase in load demand in the Houston area.
TD SYNNEX Growth: TD SYNNEX reported a total return of just under 30% in 2025, driven by strong demand for data center solutions, although it operates on low margins in the IT distribution sector.
EMCOR's Impressive Returns: EMCOR Group delivered a 35% total return in 2025 and announced a 60% increase in its quarterly dividend, reflecting robust performance and strong organic growth in the data center market.

- Analyst Rating Update: UBS analyst David Vogt maintains a Buy rating on TD SYNNEX, raising the price target from $187 to $193, reflecting optimism about the company's strategic position, particularly in AI data center infrastructure.
- Market Demand Fluctuations: Morgan Stanley analyst Erik Woodring lowers the price target from $177 to $172 while maintaining an Overweight rating, indicating confidence in the company's long-term prospects but a cautious stance on expected volatility in IT hardware demand in the near term.
- Strong Financial Performance: Barclays analyst Tim Long reduces SNX's price target from $164 to $163 but keeps an Equal Weight rating, highlighting that the company's fiscal Q4 earnings exceeded expectations due to strong software performance and consistent PC demand.
- Core of Technology Ecosystem: TD SYNNEX operates at the heart of the technology ecosystem, providing a comprehensive range of products and services from leading vendors like IBM and Cisco, designed to help partners capitalize on high-growth areas such as AI integration and hybrid cloud.
- Rating Adjustments: Goldman restarted coverage on Dell Technologies (DELL), Hewlett Packard Enterprise (HPE), TD Synnex (SNX), and Penguin Solutions (PENG) with Buy ratings, while HP (HPQ) saw its price target cut to $21, indicating a cautious outlook on its future performance.
- Market Outlook: Analysts expect IT hardware demand to face challenges in 2026; while AI infrastructure demand remains strong, traditional PC and server markets may struggle due to high costs and weak demand, impacting overall industry performance.
- Investment Recommendations: Goldman advises investors to buy Dell Technologies (DELL) and Hewlett Packard Enterprise (HPE), with Dell seen as an AI-driven earnings grower and HPE showing attractive business transformation potential, while also recommending NetApp (NTAP) for its high-margin cloud service returns.
- Industry Dynamics: Despite underperformance in IT hardware stocks in 2025, Goldman believes there are selective investment opportunities in 2026, particularly as investors focus on AI demand sustainability and cost pressures, suggesting a patient approach for potential returns.









